Huafeng Wei

Ministry of Education of the People's Republic of China — China

Immunology and Microbiology · Life Sciences

28h-index2.9kcitations89works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(29), RNA Interference and Gene Delivery(20), CAR-T cell therapy research(12), vaccines and immunoinformatics approaches(12), Monoclonal and Polyclonal Antibodies Research(11)

Publications89 total

Efficacy and safety of Shugan Jieyu capsules in combination with zolpidem for insomnia disorder with depressive symptoms: a double-blind randomized controlled trial
BMC Complementary Medicine and Therapies·2025· 1 citedOpen Access
Intravenous administration of adenosine triphosphate combined with escitalopram in major depressive disorder: protocol for a randomised, double-blind, placebo-controlled trial
BMJ Open·2025Open Access
14 (PB002): Discovery of NKT3964: a first-in-class, highly potent and selective, orally bioavailable CDK2 PROTAC degrader for cancer therapy
European Journal of Cancer·2024· 3 cited
A novel portable augmented reality surgical navigation system for maxillofacial surgery: technique and accuracy study
International Journal of Oral and Maxillofacial Surgery·2024· 1 cited
1054P A phase Ia study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of a modular CLDN18.2-targeting PG CAR-T therapy (IBI345) in patients with CLDN18.2+ solid tumors
Annals of Oncology·2023· 8 citedOpen Access
P1406: SAFETY AND EFFICACY OF IBI346, A FIRST-IN-CLASS BCMA-TARGETING MODULAR CAR-T CELL THERAPY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM TWO PHASE I STUDIES
HemaSphere·2023· 4 citedOpen Access
IL-15 armoring enhances the antitumor efficacy of claudin 18.2-targeting CAR-T cells in syngeneic mouse tumor models
Frontiers in Immunology·2023· 24 citedOpen Access
Association of the traditional Chinese medicine treatment intensity and negative conversion time of SARS-CoV-2 nuclear acid in mild COVID-19 patients
2023Open Access
Data from Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice
2023Open Access
Supplementary Data from Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice
2023Open Access
Supplementary Figures S1-S2 from Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice
2023Open Access
Data from Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice
2023Open Access
Supplementary Data from Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice
2023Open Access
Supplementary Figures S1-S2 from Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice
2023Open Access
Data from Targeted Delivery of Tumor Antigens to Activated Dendritic Cells via CD11c Molecules Induces Potent Antitumor Immunity in Mice
2023Open Access
Data from Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice
2023Open Access
Supplementary Figure Legends 1-4 from Cancer Immunotherapy Using <i>In vitro</i> Genetically Modified Targeted Dendritic Cells
2023Open Access
Supplementary Figure 1 from Cancer Immunotherapy Using <i>In vitro</i> Genetically Modified Targeted Dendritic Cells
2023Open Access
Data from Cancer Immunotherapy Using <i>In vitro</i> Genetically Modified Targeted Dendritic Cells
2023Open Access
Supplementary Methods and Materials from Cancer Immunotherapy Using <i>In vitro</i> Genetically Modified Targeted Dendritic Cells
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Bohua Li(15), Sheng Hou(9), Weizhu Qian(8), Yajun Guo(8), Jianxin Dai(7), Ingegerd Hellström(6), Karl Erik Hellström(6), Huajing Wang(6), Jian Zhao(6), Kexing Fan(5), Yajun Guo(5), Yang� Yang(5), Jian Zhao(5), Jie Gao(5), Min Tang(4), Rui Chen(4), Xuyu Zhou(4), Fan Yin(4), Geng Kou(4), Beibei Liang(4)